Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Do lupus disease activity measures detect clinically important change?

Fortin PR, Abrahamowicz M, Clarke AE, Neville C, Du Berger R, Fraenkel L, Liang MH.

J Rheumatol. 2000 Jun;27(6):1421-8.

PMID:
10852264
2.

Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians.

Chang E, Abrahamowicz M, Ferland D, Fortin PR; CaNIOS Investigators.

J Clin Epidemiol. 2002 May;55(5):488-97.

PMID:
12007552
3.
6.
7.

Impact of disease activity and cumulative damage on the health of lupus patients.

Fortin PR, Abrahamowicz M, Neville C, du Berger R, Fraenkel L, Clarke AE, Danoff D.

Lupus. 1998;7(2):101-7.

PMID:
9541094
8.

The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.

American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria.

Arthritis Rheum. 2004 Nov;50(11):3418-26.

9.
10.

Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation.

Gladman DD, Goldsmith CH, Urowitz MB, Bacon P, Bombardier C, Isenberg D, Kalunian K, Liang MH, Maddison P, Nived O, et al.

J Rheumatol. 1994 Aug;21(8):1468-71.

PMID:
7983648
12.
13.

Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices.

Moore AD, Clarke AE, Danoff DS, Joseph L, Bélisle P, Neville C, Fortin PR.

J Rheumatol. 1999 Jun;26(6):1285-90.

PMID:
10381044
14.

Small changes in outpatients lupus activity are better detected by clinical instruments than by laboratory tests.

Fortin PR, Abrahamowicz M, Danoff D.

J Rheumatol. 1995 Nov;22(11):2078-83.

PMID:
8596148
15.

Defining response in systemic lupus erythematosus: a study by the Systemic Lupus International Collaborating Clinics group.

Wollaston SJ, Farewell VT, Isenberg DA, Gordon C, Merrill JT, Petri MA, Kalunian KC; Systemic Lupus International Collaborating Clinics (SLICC).

J Rheumatol. 2004 Dec;31(12):2390-4.

PMID:
15570639
16.

Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus.

Gordon C, Wallace DJ, Shinada S, Kalunian KC, Forbess L, Braunstein GD, Weisman MH.

Rheumatology (Oxford). 2008 Mar;47(3):334-8. doi: 10.1093/rheumatology/kem342. Epub 2008 Jan 31.

17.

Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity.

Neville C, Clarke AE, Joseph L, Belisle P, Ferland D, Fortin PR.

J Rheumatol. 2000 Mar;27(3):675-9.

PMID:
10743807
18.

Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual.

Vilá LM, Alarcón GS, McGwin G Jr, Bastian HM, Fessler BJ, Reveille JD; LUMINA Study Group.

J Rheumatol. 2005 Nov;32(11):2150-5.

PMID:
16265693
Items per page

Supplemental Content

Write to the Help Desk